The specific biochemical reaction that initiated the process that eventually resulted in the development of skin blisters was the direct, non-covalent binding of the drug molecule to a specific Human Leukocyte Antigen (HLA) protein on an antigen-presenting cell, which alters the complex and leads to its recognition by and activation of cytotoxic T-lymphocytes.